RUNX1 and acute lymphoblastic leukemia: VPREB1 deletions have previously been shown to occur in up to 40% of ETV6::RUNX1-positive ALL patients at diagnosis and >70% at relapse (Kuster et al, 2011), contributing to the disordered light chain rearrangement that acts as a leukemogenic trigger (Mangum et al, 2014).